Abstract
Diabetes mellitus complicates 1-2% of all pregnancies but is associated with high a perinatal morbidity and mortality. Gestational diabetes affects up to 4% of pregnancies and is associated with foetal macrosomia (large for dates). Foetal growth is a complex process influenced by genetics, maternal factors, uterine environment and maternal and foetal hormonal status. Infants of pre-gestational diabetic mothers have an additional influence of maternal fluctuations in glycaemia. The purpose of this paper is to review maternal and foetal growth factors, including insulin, in the aetiology of macrosomia in diabetic pregnancy. Placental Growth Hormone is the major growth hormone secreted during human pregnancy. Leptin may have a role in satiety. Resistin was originally proposed as the link between obesity and diabetes but is now thought to have a more complex role. These hormones and their actions on human foetal growth are reviewed in depth with particular reference to both pre-gestational (type 1 and type 2 diabetes) and gestational diabetes. Previously, increased foetal weight in infants of diabetic mothers was thought to be as a result of maternal hyperglycaemia. It is now evident that the control of foetal growth, in normal as well as diabetic pregnancies, is far more complex than previously understood.
Keywords: Pregnancy, Diabetes, Growth factors, Maternal, Foetal
Current Diabetes Reviews
Title: A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy
Volume: 6 Issue: 2
Author(s): Mary Higgins and Fionnuala Mc Auliffe
Affiliation:
Keywords: Pregnancy, Diabetes, Growth factors, Maternal, Foetal
Abstract: Diabetes mellitus complicates 1-2% of all pregnancies but is associated with high a perinatal morbidity and mortality. Gestational diabetes affects up to 4% of pregnancies and is associated with foetal macrosomia (large for dates). Foetal growth is a complex process influenced by genetics, maternal factors, uterine environment and maternal and foetal hormonal status. Infants of pre-gestational diabetic mothers have an additional influence of maternal fluctuations in glycaemia. The purpose of this paper is to review maternal and foetal growth factors, including insulin, in the aetiology of macrosomia in diabetic pregnancy. Placental Growth Hormone is the major growth hormone secreted during human pregnancy. Leptin may have a role in satiety. Resistin was originally proposed as the link between obesity and diabetes but is now thought to have a more complex role. These hormones and their actions on human foetal growth are reviewed in depth with particular reference to both pre-gestational (type 1 and type 2 diabetes) and gestational diabetes. Previously, increased foetal weight in infants of diabetic mothers was thought to be as a result of maternal hyperglycaemia. It is now evident that the control of foetal growth, in normal as well as diabetic pregnancies, is far more complex than previously understood.
Export Options
About this article
Cite this article as:
Higgins Mary and Mc Auliffe Fionnuala, A Review of Maternal and Fetal Growth Factors in Diabetic Pregnancy, Current Diabetes Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339910790909431
DOI https://dx.doi.org/10.2174/157339910790909431 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lifestyle, Maternal Nutrition and Healthy Pregnancy
Current Vascular Pharmacology The Emerging Diabetes Online Community
Current Diabetes Reviews A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin – Molecular Mechanisms
Current Pharmaceutical Biotechnology Efficacy and Cardiovascular Safety of Insulins
Current Drug Safety Type 2 Diabetes and Asthma: Systematic Review of the Bidirectional Relationship
Current Diabetes Reviews The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs
Current Pharmacogenomics Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry Impact of Early Life Stress on the Pathogenesis of Mental Disorders: Relation to Brain Oxidative Stress
Current Pharmaceutical Design Anthropometric Correlation with Metabolic Syndrome in Sarajevo Population
Endocrine, Metabolic & Immune Disorders - Drug Targets Extrinsic Factors Promoting Insulin Producing Cell-Differentiation and Insulin Expression Enhancement-Hope for Diabetics.
Current Stem Cell Research & Therapy Effect of Vaginal Delivery on Lactose Content of Human Milk
Current Pediatric Reviews A Review on the Molecular Mechanisms Involved in the Placental Barrier for Drugs
Current Drug Delivery Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Is there a Relationship Between Gestational Diabetes and Postpartum Depression?
Current Women`s Health Reviews Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets The Role of Melanin to Dissociate Oxygen from Water to Treat Retinopathy of Prematurity
Central Nervous System Agents in Medicinal Chemistry